RE: Filtered12 Oct 2024 11:07
Dhub .. I totally agree and there is no chance of a buyout at 1p. What is more likely that a fund raise is done in October and this raises enough to get the trials started, 1st batch of patients tested and results to be obtained. If they are positive, then it is likely a pharma will want to licence or invest and the price will probably be between 5 and 10p (based on the price when the FDA approval came). At that point, Vlad may do a placing and raise more money to carry on for the next few years or sell part of the company / product.
We are all frustrated that news hasnt come yet and trials havent started but this is normal for hemo. The silence is normal and thats when the FUD spreaders and vermin come out to destroy sentiment. They have had their fun for the last 5 years but once funding is done and HOPEFULLY trials are positive, we move onto the next phase of hemo and a new investor base. I personally believe that will happen in Q1 2025.